ZHUANG Jin-qi, LU Shun, ZHANG Ming-feng. Pembrolizumab Versus Chemotherapy for PD-L1 Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(1): 34-36. DOI: 10.12019/j.issn.1671-5144.2017.01.010
Citation:
|
ZHUANG Jin-qi, LU Shun, ZHANG Ming-feng. Pembrolizumab Versus Chemotherapy for PD-L1 Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(1): 34-36. DOI: 10.12019/j.issn.1671-5144.2017.01.010
|
ZHUANG Jin-qi, LU Shun, ZHANG Ming-feng. Pembrolizumab Versus Chemotherapy for PD-L1 Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(1): 34-36. DOI: 10.12019/j.issn.1671-5144.2017.01.010
Citation:
|
ZHUANG Jin-qi, LU Shun, ZHANG Ming-feng. Pembrolizumab Versus Chemotherapy for PD-L1 Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(1): 34-36. DOI: 10.12019/j.issn.1671-5144.2017.01.010
|